Published in Trials on August 25, 2015
Group Cognitive Behavioral Therapy for IBD Patients | NCT03667586
CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ (2016) 1.60
CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud (2016) 0.99
Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trial. Pilot Feasibility Stud (2016) 0.78
Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. Children (Basel) (2017) 0.75
Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's disease. Patient Prefer Adherence (2016) 0.75
Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ (2008) 41.81
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess (1996) 16.96
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology (1976) 15.65
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut (2006) 8.08
Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract (2004) 8.06
A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol (2010) 7.47
What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials (2006) 7.32
The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol (2010) 6.81
Crohn's disease. Lancet (2012) 4.42
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology (1979) 3.94
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry (2009) 3.33
The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: a meta-analysis. J Psychosom Res (2009) 2.96
Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol (2002) 2.85
Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol (2011) 2.83
Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med (2003) 2.75
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis (2008) 2.22
Identifying and avoiding bias in research. Plast Reconstr Surg (2010) 2.19
Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis (2009) 2.15
Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med (2004) 2.10
Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res (2010) 2.07
Validation of the Mindful Attention Awareness Scale in a cancer population. J Psychosom Res (2005) 1.85
Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol (2009) 1.84
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut (2005) 1.72
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des (2004) 1.63
Mindfulness-based interventions for chronic pain: a systematic review of the evidence. J Altern Complement Med (2011) 1.54
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care (2005) 1.50
Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities. Trials (2014) 1.49
Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev (2011) 1.33
Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.30
Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health (2006) 1.26
Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial. Behav Res Ther (2010) 1.23
Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci (2006) 1.19
Personality profile and affective state of patients with inflammatory bowel disease. Gut (1989) 1.18
Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract (2012) 1.16
Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis (2006) 1.13
Effects of neuraxial blockade may be difficult to study using large randomized controlled trials: the PeriOperative Epidural Trial (POET) Pilot Study. PLoS One (2009) 1.12
Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study. Inflamm Bowel Dis (2012) 1.10
Association of participation in a mindfulness program with measures of PTSD, depression and quality of life in a veteran sample. J Clin Psychol (2011) 1.06
Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis (2008) 1.03
Dispositional mindfulness moderates the relation between neuroticism and depressive symptoms. Pers Individ Dif (2011) 1.01
"Did the trial kill the intervention?" experiences from the development, implementation and evaluation of a complex intervention. BMC Med Res Methodol (2011) 0.99
Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut (2010) 0.98
Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol Hepatol (N Y) (2012) 0.96
Baseline data in clinical trials. Med J Aust (2003) 0.95
Mindfulness-based stress reduction for people with chronic diseases. Aust J Prim Health (2010) 0.95
Gastrointestinal side effects of drugs. Expert Opin Drug Saf (2003) 0.94
Inflammatory bowel disease. Aliment Pharmacol Ther (2003) 0.94
Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis (2013) 0.93
Involving patients in research: considering good practice. Musculoskeletal Care (2013) 0.91
The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J Psychosom Res (2007) 0.91
Tinnitus rehabilitation: a mindfulness meditation cognitive behavioural therapy approach. J Laryngol Otol (2007) 0.90
Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome in children. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2010) 0.88
A pilot randomised controlled trial of a Telehealth intervention in patients with chronic obstructive pulmonary disease: challenges of clinician-led data collection. Trials (2014) 0.88
"It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterol (2007) 0.87
Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis (2014) 0.86
The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis (2013) 0.86
The INSPIRE study: do personality traits predict general quality of life (Short form-36) in distressed patients with ulcerative colitis and Crohn's disease? Scand J Gastroenterol (2008) 0.85
Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev Gastroenterol Hepatol (2009) 0.84
Therapist and relationship factors influencing dropout from individual psychotherapy: a literature review. Psychother Res (2013) 0.83
Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study. Med Klin (Munich) (1990) 0.80
Measuring individual significant change on the Beck Depression Inventory-II through IRT-based statistics. Psychother Res (2013) 0.78
Embracing complexity: what determines quality of life in inflammatory bowel disease? Eur J Gastroenterol Hepatol (2004) 0.77